147 related articles for article (PubMed ID: 31427647)
1. MRI-based 3D-printed surgical guides for breast cancer patients who received neoadjuvant chemotherapy.
Ko BS; Kim N; Lee JW; Kim HJ; Chung IY; Kim J; Lee SB; Son BH; Kim HH; Seo JB; Kim SB; Gong GY; Kim GB; Lee S; Choi SH; Ahn SH
Sci Rep; 2019 Aug; 9(1):11991. PubMed ID: 31427647
[TBL] [Abstract][Full Text] [Related]
2. 3D-MR mammography-guided breast conserving surgery after neoadjuvant chemotherapy: clinical results and future perspectives with reference to FDG-PET.
Nakamura S; Kenjo H; Nishio T; Kazama T; Do O; Suzuki K
Breast Cancer; 2001; 8(4):351-4. PubMed ID: 11791129
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of 3D-surgical guides in breast conserving surgery after neoadjuvant treatment.
Lee HS; Kim HJ; Chung IY; Kim J; Lee SB; Lee JW; Son BH; Ahn SH; Kim HH; Seo JB; Ahn JH; Gong G; Lee S; Kim N; Ko BS
Sci Rep; 2021 Feb; 11(1):3376. PubMed ID: 33564029
[TBL] [Abstract][Full Text] [Related]
4. Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer.
Bhattacharyya M; Ryan D; Carpenter R; Vinnicombe S; Gallagher CJ
Br J Cancer; 2008 Jan; 98(2):289-93. PubMed ID: 18219287
[TBL] [Abstract][Full Text] [Related]
5. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
[TBL] [Abstract][Full Text] [Related]
6. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
[TBL] [Abstract][Full Text] [Related]
7. MRI and conservative treatment of locally advanced breast cancer.
Julius T; Kemp SE; Kneeshaw PJ; Chaturvedi A; Drew PJ; Turnbull LW
Eur J Surg Oncol; 2005 Dec; 31(10):1129-34. PubMed ID: 15905068
[TBL] [Abstract][Full Text] [Related]
8. Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy.
Akazawa K; Tamaki Y; Taguchi T; Tanji Y; Miyoshi Y; Kim SJ; Ueda S; Yanagisawa T; Sato Y; Tamura S; Noguchi S
Breast J; 2006; 12(2):130-7. PubMed ID: 16509837
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the indication for breast-conservative surgery (BCS) in patients with locally-advanced breast cancer.
Mazilu L; Suceveanu AI; Tomescu D; Ciufu N; Baz R; Suceveanu AP; Parepa IR; Tofolean DE; Voinea F
Chirurgia (Bucur); 2013; 108(4):478-81. PubMed ID: 23958089
[TBL] [Abstract][Full Text] [Related]
10. Computer-aided evaluation of breast MRI for the residual tumor extent and response monitoring in breast cancer patients receiving neoadjuvant chemotherapy.
Lyou CY; Cho N; Kim SM; Jang M; Park JS; Baek SY; Moon WK
Korean J Radiol; 2011; 12(1):34-43. PubMed ID: 21228938
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of 3D-MR mammography for breast conserving surgery after neoadjuvant chemotherapy.
Nakamura S; Kenjo H; Nishio T; Kazama T; Doi O; Suzuki K
Breast Cancer; 2002; 9(1):15-9. PubMed ID: 12196716
[TBL] [Abstract][Full Text] [Related]
12. [Performances of breast magnetic resonance imaging in the context of neoadjuvant chemotherapy for breast cancer to predict pathological complete response].
Brisson C; Diguisto C; Vildé A; Body G; Arbion F; Leveque J; Ouldamer L
J Gynecol Obstet Hum Reprod; 2017 Feb; 46(2):147-154. PubMed ID: 28403971
[TBL] [Abstract][Full Text] [Related]
13. Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
Jochelson MS; Lampen-Sachar K; Gibbons G; Dang C; Lake D; Morris EA; Morrow M
Ann Surg Oncol; 2015 May; 22(5):1490-5. PubMed ID: 25777093
[TBL] [Abstract][Full Text] [Related]
14. Prospective trial of breast MRI versus 2D and 3D ultrasound for evaluation of response to neoadjuvant chemotherapy.
Lee MC; Gonzalez SJ; Lin H; Zhao X; Kiluk JV; Laronga C; Mooney B
Ann Surg Oncol; 2015 Sep; 22(9):2888-94. PubMed ID: 25589151
[TBL] [Abstract][Full Text] [Related]
15. Postchemotherapy MRI overestimates residual disease compared with histopathology in responders to neoadjuvant therapy for locally advanced breast cancer.
Kwong MS; Chung GG; Horvath LJ; Ward BA; Hsu AD; Carter D; Tavassoli F; Haffty B; Burtness BA
Cancer J; 2006; 12(3):212-21. PubMed ID: 16803680
[TBL] [Abstract][Full Text] [Related]
16. [Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in breast cancer with three-dimensional reconstruction technique].
Yang T; Zhang Z; Liu G; Mu D; Sun X; Chen Z; Liu Y; Wang C; Sun X; Wang Y
Zhonghua Wai Ke Za Zhi; 2015 Apr; 53(4):280-4. PubMed ID: 26269162
[TBL] [Abstract][Full Text] [Related]
17. A new method to optimize resection area using a radiation treatment planning system and deformable image registration for breast-conserving surgery after neoadjuvant chemotherapy.
Miyoshi T; Yamaguchi S; Fujimoto H; Yoshioka S; Shiobara M; Wakatsuki K; Suda K; Miyazawa K; Aida T; Watanabe Y; Otsuka M
Eur J Surg Oncol; 2021 Apr; 47(4):789-795. PubMed ID: 33051115
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
[TBL] [Abstract][Full Text] [Related]
19. Breast-Conserving Surgery after Neoadjuvant Chemotherapy Using a Three-Dimensional-Printed Surgical Guide Based on Supine Magnetic Resonance Imaging: A Case Report.
Wu ZY; Kim GB; Choi S; Lee S; Kim N; Ko B
J Breast Cancer; 2021 Apr; 24(2):235-240. PubMed ID: 33818018
[TBL] [Abstract][Full Text] [Related]
20. Semi-automated delineation of breast cancer tumors and subsequent materialization using three-dimensional printing (rapid prototyping).
Schulz-Wendtland R; Harz M; Meier-Meitinger M; Brehm B; Wacker T; Hahn HK; Wagner F; Wittenberg T; Beckmann MW; Uder M; Fasching PA; Emons J
J Surg Oncol; 2017 Mar; 115(3):238-242. PubMed ID: 27966220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
